1
|
Buendia MA and Neuveut C: Hepatocellular
carcinoma. Cold Spring Harb Perspect Med. 5:a0214442015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lamontagne RJ, Bagga S and Bouchard MJ:
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res.
2:163–186. 2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ma J, Sun T, Park S, Shen G and Liu J: The
role of hepatitis B virus X protein is related to its differential
intracellular localization. Acta Biochim Biophys Sin (Shanghai).
43:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gao WY, Li D, Cai DE, Huang XY, Zheng BY,
Huang YH, Chen ZX and Wang XZ: Hepatitis B virus X protein
sensitizes HL-7702 cells to oxidative stress-induced apoptosis
through modulation of the mitochondrial permeability transition
pore. Oncol Rep. 37:48–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zou LY, Zheng BY, Fang XF, Li D, Huang YH,
Chen ZX, Zhou LY and Wang XZ: HBx co-localizes with COXIII in
HL-7702 cells to upregulate mitochondrial function and ROS
generation. Oncol Rep. 33:2461–2467. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zheng BY, Fang XF, Zou LY, Huang YH, Chen
ZX, Li D, Zhou LY, Chen H and Wang XZ: The co-localization of HBx
and COXIII upregulates COX-2 promoting HepG2 cell growth. Int J
Oncol. 45:1143–1150. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Li D, Ding J, Chen Z, Chen Y, Lin N, Chen
F and Wang X: Accurately mapping the location of the binding site
for the interaction between hepatitis B virus X protein and
cytochrome c oxidase III. Int J Mol Med. 35:319–324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Cheng AS, Yu J, Lai PB, Chan HL and Sung
JJ: COX-2 mediates hepatitis B virus X protein abrogation of
p53-induced apoptosis. Biochem Biophys Res Commun. 374:175–180.
2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chen H, Cai W, Chu ESH, Tang J, Wong CC,
Wong SH, Sun W, Liang Q, Fang J, Sun Z and Yu J: Hepatic
cyclooxygenase-2 overexpression induced spontaneous hepatocellular
carcinoma formation in mice. Oncogene. 36:4415–4426. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Vilchez V, Turcios L, Marti F and Gedaly
R: Targeting Wnt/β-catenin pathway in hepatocellular carcinoma
treatment. World J Gastroenterol. 22:823–832. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Xie Q, Chen L, Shan X, Shan X, Tang J,
Zhou F, Chen Q, Quan H, Nie D, Zhang W, et al: Epigenetic silencing
of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma
cell tumorigenicity through Wnt signaling pathway. Int J Cancer.
135:635–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Daud M, Rana MA, Husnain T and Ijaz B:
Modulation of Wnt signaling pathway by hepatitis B virus. Arch
Virol. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lim K, Han C, Xu L, Isse K, Demetris AJ
and Wu T: Cyclooxygenase-2-derived prostaglandin E2 activates
beta-catenin in human cholangiocarcinoma cells: Evidence for
inhibition of these signaling pathways by omega 3 polyunsaturated
fatty acids. Cancer Res. 68:553–560. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu N, Zhou N, Chai N, Liu X, Jiang H, Wu
Q and Li Q: Helicobacter pylori promotes angiogenesis depending on
Wnt/beta-catenin-mediated vascular endothelial growth factor via
the cyclooxygenase-2 pathway in gastric cancer. BMC Cancer.
16:3212016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Qinglin L, Xin W, Zhong L, Fang L, Cao G
and Huang P: A study on the anti-tumor mechanism of total
flavonoids from Radix Tetrastigmae against additional cell line
based on COX-2-mediated Wnt/β-catenin signaling pathway.
Oncotarget. 8:54304–54319. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Tang R, Kong F, Hu L, You H, Zhang P, Du W
and Zheng K: Role of hepatitis B virus X protein in regulating LIM
and SH3 protein 1 (LASP-1) expression to mediate proliferation and
migration of hepatoma cells. Virol J. 9:1632012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lim W, Kwon SH and Cho H, Kim S, Lee S,
Ryu WS and Cho H: HBx targeting to mitochondria and ROS generation
are necessary but insufficient for HBV-induced cyclooxygenase-2
expression. J Mol Med (Berl). 88:359–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang HJ, Jiang JH, Yang YT, Yang XD, Guo
Z, Qi YP, Zeng FH, Zhang KL, Chen NZ, Xiang BD and Li LQ:
Cyclooxygenase-2 expression is associated with initiation of
hepatocellular carcinoma, while prostaglandin receptor-1 expression
predicts survival. World J Gastroenterol. 22:8798–8805. 2016.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Tian Y, Xiao X, Gong X, Peng F, Xu Y,
Jiang Y and Gong G: HBx promotes cell proliferation by disturbing
the cross-talk between miR-181a and PTEN. Sci Rep. 7:400892017.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Shen L, Zhang X, Hu D, Feng T, Li H, Lu Y
and Huang J: Hepatitis B virus X (HBx) play an anti-apoptosis role
in hepatic progenitor cells by activating Wnt/β-catenin pathway.
Mol Cell Biochem. 383:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Sobolewski C, Cerella C, Dicato M,
Ghibelli L and Diederich M: The role of cyclooxygenase-2 in cell
proliferation and cell death in human malignancies. Int J Cell
Biol. 2010:2151582010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tang X, Wang Y, Fan Z, Ji G, Wang M, Lin
J, Huang S and Meltzer SJ: Klotho: A tumor suppressor and modulator
of the Wnt/β-catenin pathway in human hepatocellular carcinoma. Lab
Invest. 96:197–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Sun Q, Wang R, Luo J, Wang P, Xiong S, Liu
M and Cheng B: Notch1 promotes hepatitis B virus X protein-induced
hepatocarcinogenesis via Wnt/β-catenin pathway. Int J Oncol.
45:1638–1648. 2014. View Article : Google Scholar : PubMed/NCBI
|